Objective: To examine the clinical efficacy and safety of tenofovir ester combined with adefovir in the treatment of chronic hepatitis B (CHB).Methods: The 130 patients with chronic hepatitis B admitted from January 2...
Supported by the China National Science and Technology Major Projects,11th 5-year Project(No.2008ZX10005-006)。
Objective:To evaluate the effects of a 48-week course of adefovir dipivoxil(ADV)plus Chinese medicine(CM)therapy,namely Tiaogan Jianpi Hexue(调肝健脾和血)and Tiaogan Jiedu Huashi(调肝解毒化湿)fomulae,in hepatitis B e ...
AIM To demonstrate the non-inferiority(15% non-inferiority limit) of monotherapy with tenofovir disoproxil fumarate(TDF) vs the combination of lamivudine(LAM) plus adefovir dipivoxil(ADV) in the maintenance of virolog...
supported by grants from National Science and Technology Major Project for Infectious Diseases of China(No.2013ZX10002001-001-006);the National Natural Science Foundation of China(No.81461130019);Deutsche Forschungsgemeinschaft(No.Transregio TRR60)
This study aims to explore the efficacy of interferon-α(IFN-α) combined with either entecavir(ETV) or adefovir(ADV) therapy versus IFN-α mono-therapy for chronic hepatitis B(CHB) patients, and to identify t...
Oral nucleoside/nucleotide analogues(NAs) are currently the backbone of chronic hepatitis B(CHB) infection treatment. They are generally well-tolerated by patients and safe to use. To date, a significant number of pat...
Objective:To explore the effect of adefovir dipivoxil in combined with lamivudine on the liver function in patients with hepatitis B cirrhosis and the antiviral efficacy.Methods:A total of 156 patients with hepatitis ...
Supported by Research Funds from the Korean Association for the Study of the Liver(in part)
AIM: To evaluate the long-term efficacy adefovir(ADV)-based combination therapies in entecavir(ETV)-resistant chronic hepatitis B(CHB) patients. METHODS: F i fty CHB pat ient s wi t h genotypic resistance to ETV at 13...
Hepatocellular carcinoma(HCC) is a major health problem worldwide, representing one of the leading causes of death. Chronic hepatitis B virus(HBV) infection(CHB) is the most important etiologic factor of this tumor, a...
support and facilities received from Ranbaxy Research Laboratories Gurgaon,India
An analytical method based on solid phase extraction was developed and validated for analysis of adefovir in human plasma. Adefovir-d4 was used as an internal standard and Synergi MAX RP80A (150rnmx4.6mm. 41am) colu...
Supported by National Key Program for Infectious Diseases of China(to Yang YD),No.2013ZX10002001;12th FiveYear Significant New Drugs Creation Plan of the Ministry of Science and Technology of China(to Yang YD),No.2011ZX09302-003-03
AIM: To evaluate urine β2-microglobulin(β2-M), retinol-binding protein(RBP) excretion, and renal impairment with adefovir dipivoxil(ADV) for chronic hepatitis B. METHODS: We enrolled 165 patients with chronic hepati...